Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Clinical
EMA issues advice on casirivimab and imdevimab antibody cocktail for the…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Clinical
Incyte Announces the Validation by the European Medicines Agency of its…
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Abcam to Report Interim Results on Monday, March 8, 2021
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Home
Commercial
Pricing
Pricing
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pricing
US govt aims at high insulin prices with plan for $35 copay in Medicare ...
Firstwordpharma News
-
March 11, 2020
Pricing
Utah lawmakers advance bill targeting insulin costs ...
Pricing
Utah lawmakers advance bill targeting insulin costs ...
Pricing
People often skip neurological meds when out-of-pocket costs rise ...
Pricing
Paracetamol prices up 40% as coronavirus shuts China ...
Pricing
EO imposes price cap on 133 medicines ...
Firstwordpharma News
-
February 17, 2020
0
Pricing
Despite Calls to Lower Drug Prices, More than 600 Medications Saw...
Biospace News
-
February 7, 2020
0
Pricing
Medicare Could Save Billions If Allowed to Negotiate Insulin Prices ...
Firstwordpharma News
-
February 4, 2020
0
Pricing
XORTX Announces Re-Pricing of Private Placement
Firstwordpharma News
-
February 2, 2020
0
Pricing
Eli Lilly prices migraine therapy at $640 for pack of 8...
Firstwordpharma News
-
January 31, 2020
0
1
2
3
...
12
Page 1 of 12
- Advertisement -
MOST POPULAR
Calculated Percentage Pain-Reduction Scores Correlate Modestly With Those Reported by Patients...
March 12, 2019
Vivante Health Announces Collaboration with Janssen for Predictive Disease Modeling –...
March 18, 2020
Apotex Corp. Issues Voluntary Nationwide Recall of Drospirenone and Ethinyl Estradiol...
March 1, 2019
Fate Therapeutics Announces FDA Clearance of IND Application for First-ever iPSC-derived...
July 12, 2020
Load more
HOT NEWS
Deals
ITM expands PSMA-617 supply agreement for no-carrier-added Lutetium-177
Commercial
Acacia Pharma Group plc: Notice of Annual General Meeting Brussels Stock...
Commercial
Milestone Pharmaceuticals Appoints Paul Edick Chairman of its Board of Directors
Therapy areas
Osivax Enters Agreement with U.S. National Institutes of Health to Test...
